Titan Pharmaceuticals
TTNP
#10131
Rank
โ‚ฌ2.98 M
Marketcap
3,26ย โ‚ฌ
Share price
3.36%
Change (1 day)
-30.98%
Change (1 year)

Revenue for Titan Pharmaceuticals (TTNP)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of โ‚ฌ0 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.05 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Titan Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 โ‚ฌ0 M-98.41%
2022 โ‚ฌ0.05 M-74.14%
2021 โ‚ฌ0.21 M79.1%
2020 โ‚ฌ0.12 M-89.59%
2019 โ‚ฌ1.17 M-77.18%
2018 โ‚ฌ5.16 M2784.03%
2017 โ‚ฌ0.17 M-98.75%
2016 โ‚ฌ14.32 M837.17%
2015 โ‚ฌ1.52 M-49.01%
2014 โ‚ฌ2.99 M-60.51%
2013 โ‚ฌ7.58 M41.06%
2012 โ‚ฌ5.38 M71.76%
2011 โ‚ฌ3.13 M-58.72%
2010 โ‚ฌ7.58 M13661.26%
2009 โ‚ฌ0.05 M
2006 โ‚ฌ0.02 M-67.72%
2005 โ‚ฌ0.07 M
2002 โ‚ฌ2.76 M-46.56%
2001 โ‚ฌ5.17 M159.41%
2000 โ‚ฌ1.99 M477.05%
1999 โ‚ฌ0.34 M36.8%
1998 โ‚ฌ0.25 M-98.31%
1997 โ‚ฌ14.91 M3440%
1996 โ‚ฌ0.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.18 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ9.62 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ84.60 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ48.18 BN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ0.60 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA